180 results on '"Colafella, Katrina"'
Search Results
2. Dietary sodium restriction prevents vascular endothelial growth factor inhibitor-induced hypertension
3. A roadmap of strategies to support cardiovascular researchers: from policy to practice
4. Angiotensinogen Suppression: A New Tool to Treat Cardiovascular and Renal Disease
5. Cyclooxygenase-2 inhibition prevents renal toxicity but not hypertension during sunitinib treatment
6. Thrombomodulin is upregulated in the kidneys of women with pre-eclampsia
7. Antihypertensives and Antibiotics: Impact on Intestinal Dysfunction and Hypertension
8. Angiotensin II infusion enhances renal aminopeptidase expression in female but not male mice
9. Interference With the Renin–Angiotensin System (RAS): Classical Inhibitors and Novel Approaches
10. Highlights from the International Society of Hypertensionʼs New Investigators Network during 2019
11. Targeting angiotensinogen with RNA-based therapeutics
12. Strong and Sustained Antihypertensive Effect of Small Interfering RNA Targeting Liver Angiotensinogen
13. Dietary sodium restriction prevents vascular endothelial growth factor inhibitor-induced hypertension
14. Abstract P068: Dietary Sodium Restriction Prevents Vascular Endothelial Growth Factor Inhibitor-Induced Hypertension
15. Conventional Vasopressor and Vasopressor‐Sparing Strategies to Counteract the Blood Pressure–Lowering Effect of Small Interfering RNA Targeting Angiotensinogen
16. Kidney Angiotensin in Cardiovascular Disease: Formation and Drug Targeting
17. CYCLOOXYGENASE-2 INHIBITION AS A NEW TOOL TO COMBAT ANGIOGENESIS INHIBITOR-INDUCED HYPERTENSION AND RENAL TOXICITY
18. Differential effects of cyclo-oxygenase 1 and 2 inhibition on angiogenesis inhibitor-induced hypertension and kidney damage
19. Kidney Angiotensin in Cardiovascular Disease:Formation and Drug Targeting
20. Angiotensinogen Suppression:A New Tool to Treat Cardiovascular and Renal Disease
21. Cyclooxygenase-2 inhibition as a new tool to combat angiogenesis inhibitor-induced hypertension and renal toxicity
22. Strategies to support early- and mid-career cardiovascular researchers to thrive
23. Relaxin Attenuates Organ Fibrosis via an Angiotensin Type 2 Receptor Mechanism in Aged Hypertensive Female Rats
24. Abstract 05: Cyclooxygenase-2 Inhibition As A New Tool To Combat Angiogenesis Inhibitor-induced Hypertension And Renal Toxicity
25. In Aged Females, the Enhanced Pressor Response to Angiotensin II Is Attenuated By Estrogen Replacement via an Angiotensin Type 2 Receptor-Mediated Mechanism
26. Cardiovascular toxicity of angiogenesis inhibitors and immune checkpoint inhibitors: synergistic anti-tumour effects at the cost of increased cardiovascular risk?
27. The effect of age on blood pressure response by 4‐week treatment perindopril: A pooled sex‐specific analysis of the EUROPA, PROGRESS, and ADVANCE trials
28. The effect of age on blood pressure response by 4-week treatment perindopril:A pooled sex-specific analysis of the EUROPA, PROGRESS, and ADVANCE trials
29. Thrombomodulin is upregulated in the kidneys of women with pre-eclampsia
30. Lack of Strategic Funding and Long-Term Job Security Threaten to Have Profound Effects on Cardiovascular Researcher Retention in Australia
31. LACK OF FUNDING AND LONG-TERM JOB SECURITY THREATENS TO HAVE PROFOUND EFFECTS ON CARDIOVASCULAR RESEARCHER RETENTION IN AUSTRALIA
32. DOCA-SALT DIMINISHES BRAIN RAS ACTIVITY IN PARALLEL WITH PLASMA AND RENAL RAS ACTIVITY – NO EVIDENCE FOR SELECTIVE BRAIN RAS ACTIVATION
33. ACE2 CONTRIBUTES TO THE NORMAL REGULATION OF ARTERIAL PRESSURE AND IMMUNITY IN FEMALES OF REPRODUCTIVE AGE
34. CONTROL OF ANTIHYPERTENSIVE EFFECT MEDIATED BY SMALL INTERFERING RNA TARGETING ANGIOTENSINOGEN
35. Aspirin for the prevention and treatment of pre-eclampsia: A matter of COX-1 and/or COX-2 inhibition?
36. No evidence for brain renin–angiotensin system activation during DOCA-salt hypertension
37. Insulin-regulated aminopeptidase deficiency impairs cardiovascular adaptations and placental development during pregnancy
38. Salt-sensitive hypertension in chronic kidney disease: distal tubular mechanisms
39. Placental effects and transfer of sildenafil in healthy and preeclamptic conditions
40. Cardiovascular toxicity of angiogenesis inhibitors and immune checkpoint inhibitors: synergistic anti-tumour effects at the cost of increased cardiovascular risk?
41. Selective ETA vs. dual ETA/B receptor blockade for the prevention of sunitinib-induced hypertension and albuminuria in WKY rats
42. AT1R-AT2R-RXFP1 Functional Crosstalk in Myofibroblasts: Impact on the Therapeutic Targeting of Renal and Cardiac Fibrosis
43. Aspirin for the prevention and treatment of pre‐eclampsia: A matter of COX‐1 and/or COX‐2 inhibition?
44. Abstract P2031: Control Of Antihypertensive Effect Of Small Interfering RNA Targeting Angiotensinogen
45. The renin-angiotensin-aldosterone system and its therapeutic targets
46. Abstract P2030: DOCA-Salt Diminishes Brain RAS Activity In Parallel With Plasma And Renal RAS Activity - No Evidence For Selective Brain RAS Activation
47. Placental effects and transfer of sildenafil in healthy and preeclamptic conditions
48. Human Placental Vascular Reactivity in Health and Disease: Implications for the Treatment of Pre-eclampsia
49. Endothelin receptor antagonism during preeclampsia: a matter of timing?
50. Vascular Cardio-Oncology: Vascular Endothelial Growth Factor inhibitors and hypertension
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.